This is a non-core endpoint: only basic statistics are computed.
Ovarian dysfunction: androgen excess
DOID EFO MESH SNOMED Endpoint Browser
E4_ODANDRO
ovarian disease: A disease involving the ovary.
Endpoint definition
↥429209 individuals
Apply sex-specific rule
239906
Check conditions None
239906
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
45
Check minimum number of events None
45
Include endpoints None
45
Remove individuals based on genotype QC
42
Control definitions
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Ovarian dysfunction: androgen excess based on the number of shared cases.
Broader endpoints:
- Ovarian dysfunction
- Disorders of other endocrine glands
- Endocrine, nutritional and metabolic diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 42 | 42 | - |
Unadjusted prevalence (%) | 0.01 | 0.02 | - |
Mean age at first event (years) | 32.74 | 32.74 | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_ODANDRO – Ovarian dysfunction: androgen excess
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Ovarian dysfunction: androgen excess
↥Endpoint not on priority list, no data to show.